Gardner Russo & Gardner Trimmed Bb&T (BBT) Stake; Gtx (GTXI) Shorts Up By 36.51%

June 14, 2018 - By Ash

BB&T Corporation (NYSE:BBT) Logo

Gtx Inc (NASDAQ:GTXI) had an increase of 36.51% in short interest. GTXI’s SI was 543,300 shares in June as released by FINRA. Its up 36.51% from 398,000 shares previously. With 156,000 avg volume, 4 days are for Gtx Inc (NASDAQ:GTXI)’s short sellers to cover GTXI’s short positions. The SI to Gtx Inc’s float is 4.84%. The stock increased 0.42% or $0.08 during the last trading session, reaching $19.34. About 63,053 shares traded. GTx, Inc. (NASDAQ:GTXI) has risen 489.32% since June 14, 2017 and is uptrending. It has outperformed by 476.75% the S&P500. Some Historical GTXI News: ; 30/05/2018 – DEUTSCHE BOERSE AG DB1Gn.DE SAYS HAS REACHED A DEFINITIVE AGREEMENT TO ACQUIRE GTX’S ECN BUSINESS FROM GAIN CAPITAL HOLDINGS INC. FOR 100 MILLION US DOLLAR; 17/05/2018 – Tech Radar: Nvidia GTX 1180 Founders Edition looks set to rock PCs in July; 26/04/2018 – ClinicalTrial US: Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) Stress Urinary; 22/03/2018 – GTX Corp Issued New Patent and GPS SmartSoles Win Second Place in Tomorrow’s Care 2018 Awards; 10/04/2018 – GTX Corp Finishes Delivery of Initial Military Order and Comments on 2017 Financial Results; 20/05/2018 – Neowin.net: Nvidia GTX 1180 Founders Edition to reportedly debut on June 15; 12/03/2018 GTx 4Q Loss/Shr 43c; 14/03/2018 – GTX Corp Prepares to Launch New Suite of GPS Tracking Solutions Expanding Beyond the Alzheimer’s Market; 10/05/2018 – GTX Corp Joins Forces With National Police Athletics League to Launch New Children Size SmartSoles; 30/05/2018 – Deutsche Boerse to Buy GTX’s ECN Business From GAIN Capital for $100M

Gardner Russo & Gardner Llc decreased Bb&T Corp (BBT) stake by 38.42% reported in 2018Q1 SEC filing. Gardner Russo & Gardner Llc sold 10,415 shares as Bb&T Corp (BBT)’s stock declined 1.68%. The Gardner Russo & Gardner Llc holds 16,690 shares with $869,000 value, down from 27,105 last quarter. Bb&T Corp now has $40.89B valuation. The stock decreased 2.51% or $1.35 during the last trading session, reaching $52.44. About 5.67M shares traded or 44.44% up from the average. BB&T Corporation (NYSE:BBT) has risen 28.68% since June 14, 2017 and is uptrending. It has outperformed by 16.11% the S&P500. Some Historical BBT News: ; 13/03/2018 BB&T names Rhodes to lead Greater Delaware Valley region; 24/04/2018 – BB&T BOOSTS QTR DIV/SHR TO 37.5C FROM 33C, EST. 33C; 25/05/2018 – BB&T CORP: FILES FOR MIXED SECURITIES OFFERING; 20/03/2018 – BB&T Retirement and Institutional Services receives 32 Best-In-Class Awards; 06/04/2018 – Regions Financial Agrees to Sell Insurance Business to BB&T Insurance Holdings; 19/04/2018 – BB&T 1Q EPS 94c; 06/04/2018 – BB&T CORP – CAPITAL USED IN DEAL WILL IMPACT BB&T’S 2018 COMPREHENSIVE CAPITAL ANALYSIS AND REVIEW; 19/04/2018 – BB&T 1Q Adj EPS 97c; 19/04/2018 – BB&T 1Q Effective Tax Rate 19%; 24/04/2018 – BB&T announces second-quarter dividends

Gardner Russo & Gardner Llc increased Brown (NYSE:BF.B) stake by 1.34 million shares to 2.82 million valued at $153.22 million in 2018Q1. It also upped Unilever Nv Adr (NYSE:UN) stake by 471,041 shares and now owns 15.25M shares. Vulcan Materials (NYSE:VMC) was raised too.

Among 32 analysts covering BB&T Corp (NYSE:BBT), 16 have Buy rating, 0 Sell and 16 Hold. Therefore 50% are positive. BB&T Corp had 112 analyst reports since July 17, 2015 according to SRatingsIntel. SunTrust maintained BB&T Corporation (NYSE:BBT) on Thursday, April 19 with “Buy” rating. The stock has “Hold” rating by BMO Capital Markets on Thursday, July 20. Keefe Bruyette & Woods maintained BB&T Corporation (NYSE:BBT) rating on Tuesday, October 3. Keefe Bruyette & Woods has “Hold” rating and $48.0 target. On Tuesday, November 15 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. The firm earned “Buy” rating on Thursday, February 8 by BMO Capital Markets. The company was maintained on Thursday, January 18 by Robert W. Baird. On Friday, September 15 the stock rating was maintained by Jefferies with “Hold”. On Friday, August 4 the stock rating was upgraded by Macquarie Research to “Hold”. The company was upgraded on Monday, January 25 by Hilliard Lyons. As per Wednesday, June 29, the company rating was downgraded by Sandler O’Neill.

Investors sentiment decreased to 1.12 in Q1 2018. Its down 0.03, from 1.15 in 2017Q4. It worsened, as 36 investors sold BBT shares while 301 reduced holdings. 110 funds opened positions while 268 raised stakes. 481.29 million shares or 0.34% more from 479.66 million shares in 2017Q4 were reported. Barton Investment Mngmt, Pennsylvania-based fund reported 1,500 shares. Peddock Advisors Limited Liability invested in 0.03% or 1,014 shares. Fcg Advsrs Lc invested in 7,148 shares. State Of New Jersey Common Pension Fund D accumulated 263,000 shares or 0.05% of the stock. Gofen Glossberg Il holds 0.53% of its portfolio in BB&T Corporation (NYSE:BBT) for 272,654 shares. Stonebridge Advisors Limited Liability Company accumulated 154,648 shares. Rowland Counsel Adv reported 116,472 shares. Miracle Mile Advisors Lc accumulated 28,867 shares. Washington Trust reported 0.63% in BB&T Corporation (NYSE:BBT). Verity Verity Ltd Liability Corporation reported 185,304 shares. Fdx Advisors invested in 53,034 shares or 0.08% of the stock. Bluemountain Capital Mgmt Llc reported 28,734 shares. 8,791 are held by Moody Natl Bank Division. State Common Retirement Fund owns 2.01 million shares for 0.13% of their portfolio. Texas Permanent School Fund has invested 0.14% of its portfolio in BB&T Corporation (NYSE:BBT).

Analysts await BB&T Corporation (NYSE:BBT) to report earnings on July, 19. They expect $1.01 earnings per share, up 29.49% or $0.23 from last year’s $0.78 per share. BBT’s profit will be $787.55 million for 12.98 P/E if the $1.01 EPS becomes a reality. After $0.97 actual earnings per share reported by BB&T Corporation for the previous quarter, Wall Street now forecasts 4.12% EPS growth.

Another recent and important BB&T Corporation (NYSE:BBT) news was published by Seekingalpha.com which published an article titled: “Auto lenders take on more risk to attract more customers: WSJ” on June 11, 2018.

Since January 19, 2018, it had 0 buys, and 16 selling transactions for $25.26 million activity. Yates William Rufus also sold $882,345 worth of BB&T Corporation (NYSE:BBT) shares. Standridge Brantley J also sold $167,146 worth of BB&T Corporation (NYSE:BBT) shares. QUBEIN NIDO R had sold 21,025 shares worth $1.15 million on Monday, February 5. Another trade for 80,789 shares valued at $4.35 million was sold by KING KELLY S. Shares for $1.25 million were sold by Starnes Clarke R III on Tuesday, February 20. Powell Cynthia B sold $151,504 worth of stock or 2,817 shares. Goodrich Donna C also sold $2.41 million worth of BB&T Corporation (NYSE:BBT) on Wednesday, April 25.

Among 3 analysts covering GTx (NASDAQ:GTXI), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. GTx had 5 analyst reports since August 10, 2016 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Wednesday, August 10. The company was maintained on Friday, December 9 by Jefferies. Robert W. Baird maintained the stock with “Buy” rating in Monday, March 5 report.

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other medical conditions. The company has market cap of $464.76 million. It focuses on the development of selective androgen receptor modulators for the treatment of breast cancer, stress urinary incontinence (SUI), and Duchenne muscular dystrophy (DMD); and selective androgen receptor degraders (SARDs) to treat progressive castration-resistant prostate cancer (CRPC). It currently has negative earnings. The companyÂ’s lead SARM candidate is the enobosarm GTx-024, a Phase II open-label proof-of-concept clinical trial for patients with advanced androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI.

More news for GTx, Inc. (NASDAQ:GTXI) were recently published by: Globenewswire.com, which released: “Detailed Research: Economic Perspectives on First Mid-Illinois Bancshares, GTx, Ferroglobe, SunOpta, Bandwidth …” on June 05, 2018. Benzinga.com‘s article titled: “Benzinga’s Daily Biotech Pulse: AstraZeneca’s Q1, Novartis-Amgen Migraine Drug Approved” and published on May 18, 2018 is yet another important article.

BB&T Corporation (NYSE:BBT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>